≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of vagina, including Hilmo

Endpoint Browser PheWeb

C3_VAGINA_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

only females

293145

2. Check conditions

None

293145

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C52
  • Hospital discharge: ICD-9 — 1840
  • Hospital discharge: ICD-8 — 1840
  • Cause of death: ICD-10 — C52
  • Cause of death: ICD-9 — 1840
  • Cause of death: ICD-8 — 1840
  • Cancer registry: Topography ICD-O-3 — C52
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

128

4. Check minimum number of events

None

128

5. Include endpoints

None

128

6. Filter based on genotype QC (FinnGen only)

124

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 124 124 -
Unadjusted period prevalence (%) 0.04 0.04 -
Median age at first event (years) 65.77 65.77 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
128
Matched controls
1280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
89.7
96.9
53
10
A04AA01
ATC
ondansetron; systemic, rectal
44.3
71.8
46
16
128
Kela drug reimbursment
Cancers of female genital organs
+∞
64.0
56
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
62.8
55
*
LEB00
NOMESCO Finland
Biopsy of vagina
139.9
55.5
56
7
XX3DW
NOMESCO Finland
Time consuming IT work
24.5
52.9
42
25
A03FA01
ATC
metoclopramide; systemic, rectal
13.3
50.7
79
138
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
45.6
41
*
ULA02
NOMESCO Finland
Kolposcopy
12.7
43.7
56
74
WF002
NOMESCO Finland
Radical radiotherapy
198.7
41.5
41
*
C52.90
ICD-10 Finland
Malignant neoplasm of vagina without histologic examination
+∞
40.8
37
*
JN4AD
NOMESCO Finland
Body CT examination
15.7
40.0
40
36
JN4BD
NOMESCO Finland
Extensive body CT
18.2
37.1
33
24
C52
ICD-10 Finland
Malignant neoplasm of vagina
+∞
31.6
29
*
Z51.5
ICD-10 Finland
Palliative care
14.4
31.5
32
29
C52.99
ICD-10 Finland
Malignant tumor of the vagina, unspecified histology
+∞
28.2
26
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.2
26
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.9
28.1
52
102
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
27.0
25
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
27.0
25
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.9
26.6
80
250
N02AA05
ATC
oxycodone; systemic
6.8
25.3
57
135
A04AA02
ATC
granisetron; systemic, transdermal
+∞
24.8
23
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.7
22
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
146.3
23.5
24
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
277.7
23.4
23
*
C52.92
ICD-10 Finland
Adenocarcinoma of the vagina
+∞
22.6
21
*
B01AB10
ATC
tinzaparin; parenteral
7.2
20.2
36
66
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
65.7
19.6
22
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.5
19.0
38
78
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.1
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
18.1
17
*
130
Kela drug reimbursment
Malignant tumour
+∞
18.1
17
*
A04AD12
ATC
aprepitant; systemic
+∞
18.1
17
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
17.0
16
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.6
16.6
77
314
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
16.0
15
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
15.2
15.7
26
21
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
15.2
15.2
25
20
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
20.1
14.9
22
13
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.9
14
*
L02BG04
ATC
letrozole; oral
34.5
14.3
18
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.0
13.9
15
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.8
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.8
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.8
13
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
13.8
13
*
ZZR00
NOMESCO Finland
Flap of skin
155.8
13.7
14
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.8
13.3
18
8
UKC02
NOMESCO Finland
Cystoscopy
5.0
13.2
34
86
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.1
12.8
25
49
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.7
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.7
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.7
12
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
12.7
12
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
12.7
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.7
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.7
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
42.0
12.5
15
*
WW500
NOMESCO Finland
Blood transfusion
25.8
11.9
16
7
ZX090
NOMESCO Finland
Other technic of radiotherapy
71.7
11.8
13
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.2
11.7
18
12
X77
ICPC
Malignant neopl genital female other
+∞
11.6
11
*
LEC00
NOMESCO Finland
Partial excision of vagina
+∞
11.6
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.6
11
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.7
11.2
23
47
ZX070
NOMESCO Finland
Intensity modified radiotherapy
119.4
10.6
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
119.4
10.6
11
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
119.4
10.6
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
10.6
10
*
A79
ICPC
Malignancy NOS
+∞
10.6
10
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.6
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.6
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
10.6
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.6
10
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
32.8
9.6
12
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
107.7
9.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.5
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.5
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.4
9.5
27
73
WZC30
NOMESCO Finland
Teaching
4.1
9.1
29
85
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
17.9
8.8
13
8
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.4
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.4
8.1
16
19
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.4
7.9
12
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
84.8
7.5
8
*
LFC00
NOMESCO Finland
Partial excision of vulva
84.8
7.5
8
*
ZX120
NOMESCO Finland
Intravenous
7.4
7.4
17
26
JN4CD
NOMESCO Finland
Very extensive body CT
17.0
7.4
11
7
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.4
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.4
7
*
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
7.4
7
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.9
7.3
24
72
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
7.1
25
78
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
6.6
6.9
17
29
J01EA01
ATC
trimethoprim; systemic
2.6
6.6
63
346
HA1AA
NOMESCO Finland
X-ray mammography
5.8
6.6
18
35
B01AB05
ATC
enoxaparin; parenteral
2.6
6.6
56
291
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
8.9
6.5
13
16
TJF80
NOMESCO Finland
Ostomy education
73.4
6.5
7
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
6.3
76
464
A06AH03
ATC
naloxegol; oral
28.2
6.3
8
*
8140/3-C52.9
ICD-O-3
Adenocarcinoma, NOS, of vagina, NOS
+∞
6.3
6
*
C529, 8085, 3
ICD-O-3
+∞
6.3
6
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
6.3
6
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
TKC20
NOMESCO Finland
Catheterisation of bladder
4.3
6.2
17
44
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
6.2
22
69
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
6.1
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
33
25
17.44
36.23
1.7
1.2
—
—
—
0
0
35
63
7.27
19.94
3.7
1.3
3.77
2.77
ug/l
0.47
26
49
54
164
4.97
17.22
7.1
1.9
0.75
0.82
mmol/l
4.35
54
149
87
495
3.37
9.59
4.4
2.3
—
—
estimate
—
0
0
97
591
3.65
9.52
21.1
6.1
3.97
4.17
e9/l
0.32
91
508
73
384
3.10
9.05
3.9
1.6
—
—
—
0
0
56
264
2.99
8.29
7.0
3.6
—
—
—
0
0
28
86
3.89
8.24
1.3
1.1
—
—
—
0
0
89
547
3.06
7.96
18.1
12.8
1.28
1.22
inr
0.37
76
447
34
137
3.02
6.46
3.2
1.8
—
—
—
0
0
61
335
2.57
6.36
14.8
4.2
—
—
—
0
0
77
473
2.58
6.32
6.6
3.6
—
—
—
0
0
65
374
2.50
6.07
4.4
3.2
21.37
36.28
e6/l
0.44
52
273
14
22
7.00
6.05
1.9
1.7
—
—
—
0
0
58
320
2.49
5.89
4.1
3.0
0.40
0.56
e6/l
0.52
46
225
34
144
2.85
5.87
10.1
4.4
102.47
104.45
mmol/l
1.26
34
144
72
444
2.42
5.65
4.8
1.9
2.38
2.37
mmol/l
0.10
67
390
57
318
2.43
5.58
4.7
1.9
—
—
—
0
0
8
7
12.08
4.85
1.0
1.0
—
—
—
0
0
84
579
2.31
4.79
8.1
5.2
1.36
1.93
e9/l
7.87
73
497
29
128
2.64
4.55
2.1
1.5
—
—
—
0
0
20
72
3.11
4.53
13.3
3.3
7.57
8.71
mmol/l
0.49
20
67
84
589
2.24
4.46
8.6
5.4
0.17
0.19
e9/l
0.42
74
503
8
10
8.44
4.12
1.0
1.3
—
—
—
0
0
8
10
8.44
4.12
1.1
1.4
14.88
24.34
ng/l
—
8
10
66
434
2.08
3.99
5.2
4.3
203.10
112.76
e6/l
0.35
52
282
81
575
2.11
3.98
8.4
5.1
0.04
0.04
e9/l
0.73
71
482
79
558
2.09
3.90
5.6
3.6
6.51
6.31
ph
0.69
49
293
22
91
2.71
3.89
9.2
4.3
—
—
—
0
0
80
568
2.09
3.89
8.4
5.1
0.54
0.57
e9/l
0.30
70
476
13
35
4.01
3.72
3.1
1.3
2.57
1.19
ug/l
0.32
13
29
23
100
2.58
3.69
2.1
1.4
—
—
—
0
0
28
134
2.39
3.68
8.9
2.4
7.39
7.40
ph
0.33
20
77
58
378
1.98
3.47
8.1
4.0
0.00
0.00
estimate
-0.00
15
120
16
60
2.90
3.37
6.1
4.6
—
—
—
0
0
7
11
6.66
3.23
1.6
1.1
—
—
—
0
0
7
11
6.66
3.23
1.6
1.1
—
—
—
0
0
7
11
6.66
3.23
1.6
1.1
—
—
—
0
0
7
11
6.66
3.23
1.6
1.1
—
—
—
0
0
84
635
1.94
3.11
9.8
5.2
1.21
1.23
mmol/l
1.33
75
559
18
78
2.52
2.90
3.8
4.2
1.29
0.54
%
—
7
12
55
371
1.85
2.84
6.3
3.0
7.40
7.40
ph
0.01
41
259
54
364
1.84
2.78
9.0
4.9
—
—
—
0
0
13
49
2.84
2.72
1.7
1.2
—
—
—
0
0
89
702
1.88
2.71
7.5
4.2
0.00
0.01
estimate
0.50
17
127
17
75
2.46
2.64
3.8
4.3
0.17
0.11
%
—
6
9
87
685
1.84
2.63
7.4
4.1
0.00
0.00
estimate
-0.00
14
129
16
69
2.51
2.60
3.4
4.2
0.60
0.30
%
—
5
10
13
52
2.67
2.44
12.0
4.5
36.89
36.95
°c
0.39
13
52
17
79
2.33
2.37
2.1
1.3
—
—
—
0
0
16
73
2.36
2.32
6.6
2.2
0.53
0.61
%
0.69
16
73
46
310
1.76
2.29
6.3
4.1
1.02
1.02
kg/l
0.09
38
216
16
74
2.33
2.26
6.6
2.2
1.05
1.23
%
0.58
16
74
17
81
2.27
2.25
4.3
4.4
0.00
0.00
%
—
6
9
86
696
1.72
2.14
7.5
4.1
0.00
0.00
estimate
-0.00
17
134
38
539
0.58
2.07
1.8
1.9
1.83
1.29
mmol/l
1.45
31
461
21
113
2.03
2.07
1.8
1.2
—
—
—
0
0
9
34
2.77
1.90
6.4
4.8
3.98
3.88
mmol/l
—
9
34
23
132
1.91
1.89
6.1
4.8
7.42
7.42
ph
0.01
16
81
106
1153
0.53
1.78
5.9
6.6
2.77
2.71
mmol/l
0.27
100
1055
38
259
1.66
1.77
1.6
1.3
—
—
—
0
0
101
1113
0.56
1.77
6.7
7.0
40.01
39.60
mmol/mol
0.17
92
1041
14
70
2.12
1.66
6.4
5.8
93.82
94.40
%
0.14
14
70
30
196
1.69
1.62
4.3
3.0
1.24
4.15
e6/l
2.04
13
88
34
230
1.65
1.62
7.3
4.3
—
—
—
0
0
21
124
1.83
1.59
3.0
1.8
382.24
376.54
nmol/l
0.03
21
112
0
42
0.00
1.56
0.0
1.1
—
—
—
0
0
14
72
2.06
1.56
6.4
5.6
1.42
1.31
%
0.18
14
72
97
1072
0.61
1.52
4.7
4.6
1.45
1.26
mmol/l
2.14
92
965
43
313
1.56
1.51
2.5
2.3
2.86
3.14
mg/l
0.43
37
263
7
28
2.58
1.47
1.6
1.1
—
—
—
0
0
5
17
3.02
1.37
1.0
1.3
—
—
—
0
0
107
1148
0.59
1.30
5.9
5.6
6.02
5.96
mmol/l
0.28
99
1047
13
70
1.95
1.29
5.7
5.7
0.70
0.64
%
0.22
13
70
24
158
1.64
1.26
1.4
1.5
—
—
—
0
0
36
262
1.52
1.25
1.6
1.7
1.68
1.20
mg/l
0.58
28
206
60
489
1.43
1.17
4.6
4.1
68.15
89.76
ng/l
0.10
48
356
14
81
1.82
1.14
12.4
3.9
—
—
—
0
0
7
31
2.33
1.12
1.9
2.0
—
—
—
0
0
19
122
1.65
1.10
1.3
1.5
—
—
—
0
0
7
34
2.12
1.04
1.1
1.3
—
0.25
—
0
11
61
507
1.39
1.03
8.4
3.9
0.00
0.02
estimate
0.50
12
99
90
989
0.70
1.02
6.4
4.9
15.36
14.98
pmol/l
0.67
85
908
0
28
0.00
0.99
0.0
1.1
—
—
—
0
0
20
136
1.56
0.93
12.2
2.6
1.01
1.03
mmol/l
0.08
20
112
17
245
0.65
0.88
1.3
1.3
3.05
10.04
u/ml
—
8
88
58
489
1.34
0.86
20.2
9.5
0.00
0.00
e9/l
0.79
48
394
30
380
0.73
0.78
4.7
3.6
—
—
—
0
0
11
68
1.68
0.74
11.4
4.7
26.25
25.61
mmol/l
0.33
11
68
15
101
1.55
0.74
2.2
4.0
395.20
226.92
ng/l
0.29
15
91
20
267
0.70
0.70
1.3
1.3
21.87
37.70
iu/ml
—
7
92
117
1114
1.58
0.70
31.0
13.8
28.11
20.05
mg/l
1.99
111
871
117
1210
0.62
0.67
52.5
21.7
123.09
131.91
g/l
8.48
117
1186
117
1210
0.62
0.67
51.8
21.4
30.35
30.16
pg
0.44
117
1188
117
1210
0.62
0.67
52.0
21.7
37.47
39.57
%
5.92
117
1188
117
1209
0.62
0.64
51.7
21.5
92.15
91.21
fl
1.10
117
1187
16
114
1.46
0.62
3.6
4.2
7.45
7.37
ph
—
10
74
11
72
1.58
0.61
1.4
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
60
531
1.24
0.56
4.2
2.9
177.05
86.89
ug/l
2.00
54
490
47
408
1.24
0.51
1.7
1.7
24.77
21.57
nmol/l
0.45
41
339
10
68
1.51
0.48
3.0
3.6
7.46
7.42
ph
—
10
58
6
92
0.64
0.44
1.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
0
16
0.00
0.41
0.0
3.5
—
—
—
0
0
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
420.60
—
0
10
11
80
1.41
0.40
4.5
2.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
61.54
—
0
13
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
5
36
1.40
0.38
1.2
2.2
7.40
7.42
ph
—
5
36
6
46
1.32
0.33
2.0
1.6
—
11.80
—
0
5
6
46
1.32
0.33
1.5
1.7
—
—
—
0
0
8
106
0.74
0.30
1.3
1.1
—
—
—
0
0
117
1195
0.76
0.29
40.1
18.7
81.01
70.70
umol/l
0.93
117
1170
87
910
0.86
0.28
41.1
17.5
14.30
13.64
%
3.17
87
900
43
469
0.87
0.25
3.3
3.7
7.23
5.28
mg/mmol
0.30
26
261
27
303
0.86
0.23
1.2
1.3
0.80
2.23
u/ml
0.92
12
68
5
40
1.26
0.22
39.4
7.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
0.45
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
7.98
—
0
13
6
48
1.26
0.20
4.2
3.8
—
—
—
0
0
43
463
0.89
0.20
2.9
3.1
38.59
23.50
mg/l
0.51
27
260
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
16
182
0.86
0.16
1.4
1.2
—
—
—
0
0
9
80
1.13
0.15
6.4
3.2
1.01
1.02
ratio
—
9
74
59
614
0.93
0.12
2.2
2.2
90.83
103.97
pmol/l
1.62
35
275
40
380
1.08
0.10
4.2
3.5
—
0.00
—
0
11
116
1174
0.87
0.10
36.1
17.4
3.99
3.96
mmol/l
0.54
116
1139
5
47
1.07
0.09
1.4
1.2
—
—
—
0
0
116
1173
0.88
0.09
36.1
17.3
138.84
139.92
mmol/l
3.69
116
1142
6
58
1.04
0.08
1.8
1.2
—
—
—
0
0
8
90
0.88
0.07
1.5
1.5
—
—
—
0
0
36
358
1.01
0.00
7.7
3.7
0.00
0.00
estimate
-0.00
12
104
24
243
0.98
0.00
2.0
1.2
2.17
2.36
g/l
0.22
16
128
47
475
0.98
0.00
2.8
3.0
6.58
6.28
mmol/l
0.20
37
391
115
1148
1.02
0.00
29.7
12.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
15.24
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
70.13
—
0
8
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
58.43
—
0
7
7
78
0.89
-0.00
1.1
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
0.68
—
0
9
0
9
0.00
-0.00
0.0
1.3
—
359.11
—
0
9
0
8
0.00
-0.00
0.0
2.5
—
45.50
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
111.65
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_VAGINA_WIDE – Malignant neoplasm of vagina, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).